Piramal Pharma Limited — Important, 10-07-2025: General Updates

Piramal Pharma Limited has announced a board meeting to consider the financial results for the quarter and half-year. NSE Sustainability Ratings assigned the company an ESG score of 61 for FY 2023-24 based on publicly available data, without the company's direct involvement. No operational changes or new business developments were disclosed.